UnknownPhase 3NCT01517828
Intranasal Midazolam Versus Intranasal Ketamine to Sedate Newborns for Intubation in Delivery Room
Studying Neonatal acute respiratory distress syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Montpellier
- Principal Investigator
- Christophe CM MILESI, MDUniversity Hospital, Montpellier
- Intervention
- Sedation by ketamine(drug)
- Enrollment
- 62 target
- Eligibility
- All sexes
- Timeline
- 2012 – 2016
Study locations (3)
- Centre Hospitalier Universitaire, Montpellier, France
- Centre Hospitalier Universitaire, Nîmes, France
- Centre Hospitalier Général, Perpignan, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01517828 on ClinicalTrials.govOther trials for Neonatal acute respiratory distress syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07437391Effect of L-Carnitine Supplementation in Preterm NeonatesMuhammad Aamir Latif
- RECRUITINGNCT07154134Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress SyndromeTanta University
- RECRUITINGNCT06874478Respiratory Distress and Elective Cesarean Section at TermAssiut University
- RECRUITINGPHASE4NCT06074380Non Inferiority Trial Investigating Surfactants Administered Via MISTEndeavor Health
- RECRUITINGNCT06031324The Role of Lung Ultrasonography Score in Predicting Prognosis in Term and Late Preterm Newborns With Postnatal Respiratory DistressBursa City Hospital
See all trials for Neonatal acute respiratory distress syndrome →